Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

UNLABELLED: Bisphosphonates (BPs) are well established as the leading drugs for the treatment of osteoporosis. There is new knowledge about how they work. The differences that exist among individual BPs in terms of mineral binding and biochemical actions may explain differences in their clinical be...

Podrobná bibliografie
Hlavní autoři:	Russell, R, Watts, N, Ebetino, F, Rogers, M
Médium:	Journal article
Jazyk:	English
Vydáno:	2008

Podobné jednotky

Bisphosphonates: Mechanisms of Action
Autor: Roelofs, A, a další
Vydáno: (2008)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
Autor: Russell, R, a další
Vydáno: (2007)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
Autor: Russell, R, a další
Vydáno: (2007)

Molecular modeling of the bisphosphonates in farnesyl diphosphate synthase. potential new details of the precise biochemical mechanism of action of potent nitrogen containing bisphosphonates
Autor: Ebetino, F, a další
Vydáno: (2002)

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
Autor: Nancollas, G, a další
Vydáno: (2006)

Denosumab and bisphosphonates: different mechanisms of action and effects.
Autor: Baron, R, a další
Vydáno: (2011)

Bisphosphonates--mechanisms of action in multiple myeloma.
Autor: Shipman, C, a další
Vydáno: (2000)

A computational model delineates differences in hydroxyapatite binding affinities of bisphosphonates in clinical use
Autor: Ebetino, E, a další
Vydáno: (2005)

The pharmacology of bisphosphonates and new insights into their mechanisms of action.
Autor: Russell, R, a další
Vydáno: (1999)

Mineral binding affinities and zeta potentials of bisphosphonates
Autor: Nancollas, G, a další
Vydáno: (2002)

Investigations into the kinetic mechanism of inhibition of farnesyl diphosphate synthase by nitrogen containing bisphosphonates
Autor: Dunford, J, a další
Vydáno: (2006)

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
Autor: Kavanagh, K, a další
Vydáno: (2006)

Molecular modeling of the bisphosphonates (BPs) in farnesyl diphosphate (FPP) synthase. Proposed new mechanism of inhibition by potent nitrogen containing bisphosphonates (NBPs).
Autor: Ebetino, F, a další
Vydáno: (2002)

Analysis of the kinetic mechanism of inhibition of Farnesyl Pyrophosphate Synthase by nitrogen containing bisphosphonates.
Autor: Dunford, J, a další
Vydáno: (2006)

A computational model explains bisphosphonate binding affinity differences on hydroxyapatite
Autor: Ebetino, F, a další
Vydáno: (2006)

A computational model explains bisphosphonate binding affinity differences on hydroxyapatite
Autor: Ebetino, F, a další
Vydáno: (2006)

Bisphosphonates: mode of action and pharmacology.
Autor: Russell, R
Vydáno: (2007)

Differences between bisphosphonates in binding affinities for hydroxyapatite.
Autor: Lawson, M, a další
Vydáno: (2010)

Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo.
Autor: Roelofs, A, a další
Vydáno: (2012)

Potential bone mineral binding differences among bisphosphonates can be demonstrated by the use of hydroxyapatite column chromatography.
Autor: Lawson, M, a další
Vydáno: (2005)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
Autor: Pazianas, M, a další
Vydáno: (2010)

Bisphosphonate bone affinity, differences predicted by in vitro binding to carbonated apatite
Autor: Henneman, Z, a další
Vydáno: (2004)

Bisphosphonate bone affinity, differences predicted by in vitro carbonated apatite model.
Autor: Henneman, Z, a další
Vydáno: (2003)

Differentiation of bisphosphonates based on their physical chemical properties
Autor: Phipps, R, a další
Vydáno: (2006)

Mineral binding affinities of bisphosphonates.
Autor: Nancollas, G, a další
Vydáno: (2002)

Modeling of bisphosphonate binding to farnesyl diphosphate synthase
Autor: Ebetino, F, a další
Vydáno: (2002)

Kinetic analysis of conformational changes in farnesyl pyrophosphate synthase induced by nitrogen containing bisphosphonates
Autor: Dunford, J, a další
Vydáno: (2007)

Physiological and biological mechanisms of bisphosphonate action
Autor: Duan, X
Vydáno: (2011)

Refining the use of hydroxyapatite column chromatography to reveal differences in relative binding affinities of bisphosphonates
Autor: Lawson, M, a další
Vydáno: (2006)

BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO
Autor: Mabilleau, G, a další
Vydáno: (2010)

BONE AFFINITY DIFFERENCES OF NITROGEN-CONTAINING BISPHOSPHONATES PREDICTED BY IN VITRO BINDING TO CARBONATED APATITE
Autor: Ebetino, F, a další
Vydáno: (2004)

Bone mineral affinity influences the distribution of a bisphosphonate and a lower affinity analogue in vivo
Autor: Roelofs, A, a další
Vydáno: (2009)

New developments in bisphosphonate research. Improving our understanding of their differences mechanistically.
Autor: Ebetino, F, a další
Vydáno: (2002)

Predicting the clinical potencies of bisphosphonates: Divergence of hydroxyapatite and farnesyl diphosphate synthase binding affinities
Autor: Xia, Z, a další
Vydáno: (2007)

Molecular interactions of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase
Autor: Ebetino, F, a další
Vydáno: (2005)

The use of hydroxyapatite column chromatography as a novel method to reveal differences in relative binding affinities of bisphosphonates
Autor: Lawson, M, a další
Vydáno: (2005)

Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro.
Autor: Henneman, Z, a další
Vydáno: (2008)

Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy
Autor: Lundy, M, a další
Vydáno: (2007)

Comparative mineral binding affinities of selected bisphosphonates
Autor: Nancollas, G, a další
Vydáno: (2002)

Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
Autor: Dunford, J, a další
Vydáno: (2008)